NOX1
Basic information
Region (hg38): X:100843324-100874359
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NOX1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 30 | 40 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 12 | 2 |
Variants in NOX1
This is a list of pathogenic ClinVar variants found in the NOX1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-100844013-T-C | not specified | Uncertain significance (Feb 25, 2025) | ||
X-100844046-C-T | not specified | Likely benign (Feb 17, 2022) | ||
X-100844047-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
X-100848685-A-G | not specified | Uncertain significance (Mar 07, 2023) | ||
X-100848724-C-A | not specified | Uncertain significance (Mar 08, 2025) | ||
X-100848732-A-G | not specified | Uncertain significance (Mar 13, 2023) | ||
X-100848734-G-C | not specified | Uncertain significance (Oct 06, 2023) | ||
X-100849330-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
X-100849356-T-G | Uncertain significance (Jan 19, 2022) | |||
X-100849366-T-C | not specified | Likely benign (Jun 27, 2022) | ||
X-100849395-C-A | not specified | Uncertain significance (Feb 07, 2025) | ||
X-100849418-G-T | not specified | Uncertain significance (Jan 24, 2025) | ||
X-100849790-G-C | NOX1-related disorder • not specified | Conflicting classifications of pathogenicity (Jan 29, 2025) | ||
X-100849831-T-C | NOX1-related disorder | Likely benign (Aug 14, 2019) | ||
X-100849894-C-T | not specified | Uncertain significance (Jan 29, 2025) | ||
X-100849901-A-C | not specified | Uncertain significance (Nov 30, 2022) | ||
X-100849906-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
X-100849935-C-G | Neuroferritinopathy | Uncertain significance (Feb 25, 2025) | ||
X-100850151-C-T | NOX1-related disorder | Benign (Aug 05, 2018) | ||
X-100850161-G-T | not specified | Uncertain significance (May 09, 2023) | ||
X-100850218-G-A | Likely benign (Dec 01, 2022) | |||
X-100850229-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
X-100850238-T-A | not specified | Uncertain significance (Dec 11, 2024) | ||
X-100850304-A-G | not specified | Uncertain significance (Mar 16, 2024) | ||
X-100850349-A-G | Likely benign (Nov 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NOX1 | protein_coding | protein_coding | ENST00000372966 | 13 | 31022 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.66e-8 | 0.749 | 125658 | 46 | 40 | 125744 | 0.000342 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0507 | 210 | 208 | 1.01 | 0.0000157 | 3709 |
Missense in Polyphen | 74 | 80.507 | 0.91917 | 1613 | ||
Synonymous | 0.993 | 62 | 72.8 | 0.852 | 0.00000514 | 1051 |
Loss of Function | 1.34 | 14 | 20.6 | 0.680 | 0.00000159 | 343 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000337 | 0.000322 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000652 | 0.000489 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000272 | 0.000193 |
Middle Eastern | 0.000652 | 0.000489 |
South Asian | 0.00227 | 0.00137 |
Other | 0.00111 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: NOH-1S is a voltage-gated proton channel that mediates the H(+) currents of resting phagocytes and other tissues. It participates in the regulation of cellular pH and is blocked by zinc. NOH-1L is a pyridine nucleotide-dependent oxidoreductase that generates superoxide and might conduct H(+) ions as part of its electron transport mechanism, whereas NOH-1S does not contain an electron transport chain.;
- Pathway
- AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);Osteoclast differentiation - Homo sapiens (human);TNF alpha Signaling Pathway;Vitamin D Receptor Pathway;Signal Transduction;RHO GTPases Activate NADPH Oxidases;RHO GTPase Effectors;Signaling by Rho GTPases;RAC1 signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.282
Intolerance Scores
- loftool
- 0.134
- rvis_EVS
- 0.42
- rvis_percentile_EVS
- 77.16
Haploinsufficiency Scores
- pHI
- 0.112
- hipred
- N
- hipred_score
- 0.231
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.163
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nox1
- Phenotype
- immune system phenotype; digestive/alimentary phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype;
Gene ontology
- Biological process
- angiogenesis;regulation of systemic arterial blood pressure by renin-angiotensin;NADP metabolic process;defense response;inflammatory response;signal transduction;regulation of blood pressure;positive regulation of cell population proliferation;positive regulation of vascular endothelial growth factor production;cell migration;extracellular matrix organization;ion transmembrane transport;regulation of ion transmembrane transport;superoxide anion generation;hydrogen peroxide metabolic process;positive regulation of integrin biosynthetic process;respiratory burst;positive regulation of JNK cascade;positive regulation of smooth muscle cell proliferation;intracellular pH elevation;oxidation-reduction process;cellular response to hyperoxia;oxygen metabolic process;positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway;cellular stress response to acidic pH
- Cellular component
- early endosome;plasma membrane;cell junction;NADPH oxidase complex;invadopodium membrane
- Molecular function
- voltage-gated ion channel activity;protein binding;superoxide-generating NADPH oxidase activity;metal ion binding;Rac GTPase binding;NADP binding